Pfizer report 2011

Pfizer report 2011

Key Medicines Maintained and expanded advanced renal cell carcinoma franchise, which includes Sutent, Torisel temsirolimus and Inlyta axitinib , which is approved in the U. The products discussed herein may have different labeling in different countries. Pfizer reports quarterly on lobbying expenses. Drove Advil to become the No. We continue to drive innovations in policies, practices and disclosures on corporate political activities and other key governance areas. Ferrosan expanded our global portfolio to include leading brands within multivitamins and minerals, probiotics, omega-3s and more, such as IMEDEEN, whose proven formulas work deep in the dermal layer, where traditional skin therapies cannot reach. In , we intensified and expanded upon this approach by creating a number of Pfizer Colleague Councils, an internal network of specific groups, each with a sponsor from the Executive Leadership Team. We believe that sharing this information will help the public understand the full breadth of the important collaborative work done by industry, academia and health care professionals to advance patient health.

We do not pay health care professionals for prescribing our medicines or as an inducement for promoting our medicines, vaccines or nutritional products.

Securities and Exchange Commission and available at www. At sites in all the nations where Pfizer people work, local management is accountable for making sure that colleagues know how the business is progressing and are fully engaged in its success.

This successful campaign empowers patients with psoriatic arthritis, rheumatoid arthritis or plaque psoriasis to take action and educate themselves about their condition and work with a medical specialist to make an informed decision about treatment options.

Now we are building on the success of this program by rolling out similar fleet safety programs across the globe.

2018 financial report pfizer

We have largely reshaped the ways new medicines are brought through regulatory approval and launched, and are able, in many cases, to submit new drug applications to multiple authorities at once.

In addition, we have a robust internal audit group, with a direct reporting relationship to the Audit Committee of the Board of Directors as well as a reporting relationship to the Chief Financial Officer. For more information visit Pfizer Pharmaceutical Products.

Rated 6/10 based on 81 review
Pfizer Annual Report on Behance